Novo Chairman’s Power Grab Leaves No Doubt About Who’s in Charge

Oct. 22, 2025, 9:52 AM UTC

If there was any doubt about who truly runs Danish weight-loss drugmaker Novo Nordisk A/S, Lars Rebien Sorensen just settled it.

The former chief executive is stepping back into the limelight after almost a decade pulling the strings behind the scenes. He’s taking on the role of chairman amid a boardroom rupture over the speed of change at the company that’s quickly recasting itself after its rapid growth slowed.

Lars Rebien Sorensen
Source: Novo Nordisk Foundation

Already chairman of the Novo Nordisk Foundation — the drugmaker’s controlling shareholder — Sorensen now holds sway over both the company and the powerful entity that has more than ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.